Sildenafil Therapy Normalizes the Aberrant Metabolomic Profile in the Comt(-/-) Mouse Model of Preeclampsia/Fetal Growth Restriction.

MLA

Stanley, Joanna L., et al. “Sildenafil Therapy Normalizes the Aberrant Metabolomic Profile in the Comt(-/-) Mouse Model of Preeclampsia/Fetal Growth Restriction.” Scientific Reports, vol. 5, Dec. 2015, p. 18241. EBSCOhost, https://doi.org/10.1038/srep18241.

APA

Stanley, J. L., Sulek, K., Andersson, I. J., Davidge, S. T., Kenny, L. C., Sibley, C. P., Mandal, R., Wishart, D. S., Broadhurst, D. I., & Baker, P. N. (2015). Sildenafil Therapy Normalizes the Aberrant Metabolomic Profile in the Comt(-/-) Mouse Model of Preeclampsia/Fetal Growth Restriction. Scientific Reports, 5, 18241. https://doi.org/10.1038/srep18241

Chicago

Stanley, Joanna L, Karolina Sulek, Irene J Andersson, Sandra T Davidge, Louise C Kenny, Colin P Sibley, Rupasri Mandal, David S Wishart, David I Broadhurst, and Philip N Baker. 2015. “Sildenafil Therapy Normalizes the Aberrant Metabolomic Profile in the Comt(-/-) Mouse Model of Preeclampsia/Fetal Growth Restriction.” Scientific Reports 5 (December): 18241. doi:10.1038/srep18241.